Sign in
4

Changes in Ownership

Definium Therapeutics, Inc. Filed Acc 0000899243-22-039214

Chief Executive Officer sold 3,861 shares at $2.69 ($10,386)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Barrow Robert Chief Executive Officer 2022-12-21 Sale −3,861 $2.69 $10,386 247,232 D: show line 1 in the form
Open-market sales · 3,861 sh · avg $2.69 · $10,386
Loading xslF345X03/doc4.xml…